By Jonathan Stempel, Reuters
MasterCard Inc. said on Thursday it expects to delay its $2.45 billion initial public offering until the second quarter, after Chief Executive Bob Selander was diagnosed with prostate cancer.
The world’s second-biggest credit card association, based in Purchase, New York, had been expected to begin marketing the IPO to investors in late January, and go public by the end of March. The marketing efforts did not take place.
For this complete story, please visit MasterCard Delays IPO to Q2, CEO has Cancer.